AI Assistant for Urology Care in Kidney Stones, Enlarged Prostate and Bladder Cancer
Compares an AI urology assistant with doctor-led care in adults having urological treatment.
Plain-language title generated from the registry record
Registry title: An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models
Key facts
- Where
- Hanoi, Ho Chi Minh City, Huế, and Thu Dau Mot, VietnamSee the 4 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Source: NCT07555756, who can take part
Where in Vietnam
- Viet Duc University HospitalHanoi, VietnamNo longer taking part
- Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh CityHo Chi Minh City, VietnamNo longer taking part
- Hue Central HospitalHuế, VietnamNo longer taking part
- Binh Duong General HospitalThu Dau Mot, VietnamNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- First Affiliated Hospital of Guangxi Medical University
- Trial code
- NCT07555756
- Record updated
- 29 April 2026
- Original description
This study evaluates our team's urology-specific AI (UroMed AI Doctor) for its safety, professionalism, knowledge and Q\&A ability, and tests its effectiveness against traditional manual urology care, to confirm if it can be a safe auxiliary tool and improve patients' preoperative experience.Read full original descriptionShow less
AN INTERNATIONAL MULTICENTER CLINICAL STUDY ON APPLICATION OF UROMED AI DOCTOR BASED ON LARGE LANGUAGE MODELS
This study evaluates our team's urology-specific AI (UroMed AI Doctor) for its safety, professionalism, knowledge and Q\&A ability, and tests its effectiveness against traditional manual urology care, to confirm if it can be a safe auxiliary tool and improve patients' preoperative experience.
Before the study, we will test the AI with urology questions, compare it to international AI models (DeepSeek, ChatGPT, Google Gemini), and have two senior chief physicians evaluate it.
In the clinical trial, patients at The First Affiliated Hospital of Guangxi Medical University will be randomly split into two groups: AI-assisted care or traditional care by a specialist.
Two senior specialists will evaluate both groups blindly; each group will get preoperative education (AI or physician), with anxiety and satisfaction surveyed.
Subsequently, a multi-center validation will be conducted with 11 domestic and international hospitals.
Inclusion: Diagnosed with kidney stones, benign prostatic hyperplasia, or bladder cancer in line with the Chinese Guidelines for the Diagnosis and Treatment of Urological and Andrological Diseases (2022 Edition) and requiring hospitalization for surgery; Aged 18 to 60 years with good communication skills. Voluntarily agrees to participate in the clinical study and has signed the informed consent form.
Exclusion: Suffers from psychiatric disorders. Refuses to participate in medical activities involving the use of artificial intelligence systems; Unable to engage in effective communication with the research team. Has multiple underlying diseases with unstable clinical conditions.